logo-loader

Proactive news snapshot: Ethernity Networks, Kibo Energy, SIMEC Atlantis Energy

Some of the news from the Proactive Investors newswire on Friday

Proactive news snapshot: Ethernity Networks, Kibo Energy, SIMEC Atlantis Energy

Ethernity Networks Ltd’s (LON:ENET) interim results statement marked an expected step-change in the business as it transitioned into a solutions provider for virtual networking and security appliances.

Kibo Energy PLC’s (LON:KIBO) Mbeya coal-to-power project is “rapidly gaining momentum” now that it has made the required statutory payments to the Tanzanian authorities. The payments relate to the final processing and issuance of seven mining rights for Mbeya, which were approved and granted last month.

Tidal power specialist SIMEC Atlantis Energy Ltd (LON:SAE) said its French joint-venture has been chosen to supply the entire electricity needs of Alderney, in the Channel Islands.

Xpediator PLC (LON:XPD) has said its chief financial officer,  Stuart Howard, has stepped down from the board with immediate effect to pursue other business interests.

Battery materials producer Strategic Minerals PLC (LON:SML) has received a research and development grant worth just shy of A$300,000 from the Australian tax office. The payment recognises a portion of the works carried out at Strategic’s Leigh Creek copper mine in South Australia. 

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Ethernity Networks Ltd named herein, including the promotion by the Company of Ethernity Networks Ltd in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Faron Pharmaceuticals makes 'groundbreaking discovery' in its MATINS trial

Faron Pharmaceuticals Oy (LON:FARN) (FIRSTNORTH:FARON) CEO Dr Markku Jalkanen speaks to Proactive London's Andrew Scott after updating on its phase I/II MATINS trial of Clevegen. He says it's been encouraging to discover that Clevegen can ‘down’ regulate a range of checkpoints that affect the...

37 minutes ago

2 min read